NDC 50090-5560-01 - doxycycline hyclate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5560
- Requested NDC
- 50090-5560-01
- Package NDCs from labels
- 50090-5560-1, 50090-5560-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-04-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| doxycycline hyclate - A-S Medication Solutions | A-S Medication Solutions | 2024-04-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-5560-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-b805-0266-e053-dadaa90a7c1a | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP |
| 50090-5560-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-b805-0266-e053-dadaa90a7c1a | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5560-1 | doxycycline hyclate | 20 in 1 BOTTLE | CAPSULE | 20 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5560 | DOXYCYCLINE HYCLATE CAPSULE [A-S MEDICATION SOLUTIONS] | 8 | Current NDC, Legacy NDC, 1 package rows | 20240430_1dd7a94e-bf29-4f07-9476-ac8d1f9ab565.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5560-1 | EA - Each | 50090-5560 | dcb0fa29-3ec2-4b98-a3e4-94593b54ddb2 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline | DOXYCYCLINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2bcde264-5f6f-47f6-ae2e-1b7010deacf7 | 2025-07-18 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Bryant Ranch Prepack | b612d2f5-b703-47f0-b5eb-b66a7aeed577 | 2025-06-27 | Warnings, Adverse reactions | 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | a569ba80-ffea-40b2-9fbe-a42810b1fccb | 2025-06-26 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 6772807d-a39e-47ce-9584-a08e7f8940d2 | 2025-06-17 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | Alembic Pharmaceuticals Inc. | a50e953d-447b-4b66-b567-04586174d3f9 | 2025-06-16 | Warnings, Adverse reactions | N12000U13O |
| doxycycline | DOXYCYCLINE | Macleods Pharmaceuticals Limited | 10aca485-850b-4c82-bb7e-5fac2d7a62ce | 2025-06-07 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Dr.Reddys Laboratories Inc | 7a28cce1-4805-b3d1-4484-e7a49c597660 | 2025-06-06 | Warnings, Adverse reactions | N12000U13O |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | 81c5a7fc-3fe0-40b2-bae0-c79eb0b27697 | 2025-06-04 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Bryant Ranch Prepack | b46208a2-5072-4df5-b2af-379f865545d2 | 2025-06-02 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Asclemed USA, Inc. | bed39bae-64c2-44b4-9c95-682ead4e6738 | 2025-05-31 | Warnings, Adverse reactions | 1649988 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Asclemed USA, Inc. | a5571acf-3284-4559-8cc0-b4856ac6d94d | 2025-05-31 | Warnings, Adverse reactions | ANDA062500 1649988 19XTS3T51U |
| Doxycycline | DOXYCYCLINE | A-S Medication Solutions | 2b3b3c48-eb60-400c-bdfe-50635a136c90 | 2025-05-28 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 61195fc6-3fa7-4203-b526-477b48395856 | 2025-05-16 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 9cbd8699-e2c2-40d4-8797-e676f2a10eb2 | 2025-05-16 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | 7c33c1b8-100e-4df8-be8d-de3eed7ced94 | 2025-04-30 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | Zydus Pharmaceuticals USA Inc. | fef9580d-8850-4cbb-89eb-2b4d40ee59c9 | 2025-04-26 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline | DOXYCYCLINE | Sun Pharmaceutical Industries, Inc. | 829dbd3d-5c2b-47b8-96a5-423af78c93b9 | 2025-04-24 | Warnings, Adverse reactions | N12000U13O |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | cec4368f-2852-443d-9d6f-7ba95807021b | 2025-04-16 | Warnings, Adverse reactions | 19XTS3T51U |
| ORACEA | DOXYCYCLINE | Galderma Laboratories, L.P. | aa15c93a-ff4c-447a-8a21-96da506d8997 | 2025-04-16 | Warnings, Adverse reactions | N12000U13O |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Chartwell RX, LLC | b3294889-e8f8-42f1-9bd0-13d87572997a | 2025-04-15 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.